Caris Life Sciences, Inc. (CAI) - Dilution Analysis

Visualizing historical and potential share dilution over time

View Stock Details

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Dilution Analysis

Low Risk

Limited dilution potential

Last updated: May 08, 2026

Risk Assessment Details

Potential Dilution: 0.0% of current shares

Recent Dilution: 0% (2 years)

Historical Dilution Factor: minimal recent dilution

Outstanding Shares

280M

Potential Supply

Additional shares possible

Splits

None

Past 2 years

Summary

CAI currently has 283M outstanding shares. with minimal authorized share overhang for future dilution. The company has not diluted shareholders through share issuances in the past 2 years, which is positive for existing holders.

Share Structure Timeline

Outstanding Shares

Total Supply

Historical Data Points

Date	Event	Outstanding
May 08, 2026	10-Q filing \| 282.6M shares outstanding	280M
Jun 16, 2025	S-1/A filing: This S-1/A filing from 2025-06-16 discusses Caris Life Sciences' market opportunities in early detection, therapy selection, MRD tracking, biopharma services, and data services.	N/A
Jun 09, 2025	S-1/A filing: This S-1/A filing from Caris Life Sciences discusses their business model and market opportunities in early cancer detection, therapy selection, MRD tracking, biopharma services, and data services, highlighting their platform's advantages and future growth potential.	N/A
May 23, 2025	S-1 filing: This is an S-1 filing for an initial public offering of Class A common stock by Caris Life Sciences, Inc.	N/A

Back to CAI Details